149 related articles for article (PubMed ID: 35219699)
1. Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal Heterogeneity.
Ganguly K; Cox JL; Ghersi D; Grandgenett PM; Hollingsworth MA; Jain M; Kumar S; Batra SK
Gastroenterology; 2022 Jun; 162(7):2032-2046.e12. PubMed ID: 35219699
[TBL] [Abstract][Full Text] [Related]
2. Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance.
Ganguly K; Bhatia R; Rauth S; Kisling A; Atri P; Thompson C; Vengoji R; Ram Krishn S; Shinde D; Thomas V; Kaur S; Mallya K; Cox JL; Kumar S; Batra SK
Gastroenterology; 2022 Jan; 162(1):253-268.e13. PubMed ID: 34534538
[TBL] [Abstract][Full Text] [Related]
3. Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness.
Ganguly K; Krishn SR; Rachagani S; Jahan R; Shah A; Nallasamy P; Rauth S; Atri P; Cox JL; Pothuraju R; Smith LM; Ayala S; Evans C; Ponnusamy MP; Kumar S; Kaur S; Batra SK
Cancer Res; 2021 Jan; 81(1):91-102. PubMed ID: 33127746
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis.
Nallasamy P; Nimmakayala RK; Karmakar S; Leon F; Seshacharyulu P; Lakshmanan I; Rachagani S; Mallya K; Zhang C; Ly QP; Myers MS; Josh L; Grabow CE; Gautam SK; Kumar S; Lele SM; Jain M; Batra SK; Ponnusamy MP
Gastroenterology; 2021 Dec; 161(6):1998-2013.e7. PubMed ID: 34418441
[TBL] [Abstract][Full Text] [Related]
5. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.
Pothuraju R; Rachagani S; Krishn SR; Chaudhary S; Nimmakayala RK; Siddiqui JA; Ganguly K; Lakshmanan I; Cox JL; Mallya K; Kaur S; Batra SK
Mol Cancer; 2020 Feb; 19(1):37. PubMed ID: 32098629
[TBL] [Abstract][Full Text] [Related]
6. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.
Rachagani S; Torres MP; Kumar S; Haridas D; Baine M; Macha MA; Kaur S; Ponnusamy MP; Dey P; Seshacharyulu P; Johansson SL; Jain M; Wagner KU; Batra SK
J Hematol Oncol; 2012 Oct; 5():68. PubMed ID: 23102107
[TBL] [Abstract][Full Text] [Related]
7. RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells.
Yamazoe S; Tanaka H; Sawada T; Amano R; Yamada N; Ohira M; Hirakawa K
J Exp Clin Cancer Res; 2010 May; 29(1):53. PubMed ID: 20492722
[TBL] [Abstract][Full Text] [Related]
8. Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences.
Paunescu V; Bojin FM; Tatu CA; Gavriliuc OI; Rosca A; Gruia AT; Tanasie G; Bunu C; Crisnic D; Gherghiceanu M; Tatu FR; Tatu CS; Vermesan S
J Cell Mol Med; 2011 Mar; 15(3):635-46. PubMed ID: 20184663
[TBL] [Abstract][Full Text] [Related]
9. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
10. CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.
Purohit A; Varney M; Rachagani S; Ouellette MM; Batra SK; Singh RK
Oncotarget; 2016 Feb; 7(6):7280-96. PubMed ID: 26771140
[TBL] [Abstract][Full Text] [Related]
11. GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin.
Inaguma S; Kasai K; Ikeda H
Oncogene; 2011 Feb; 30(6):714-23. PubMed ID: 20972463
[TBL] [Abstract][Full Text] [Related]
12. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
[TBL] [Abstract][Full Text] [Related]
13. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model.
Rachagani S; Macha MA; Menning MS; Dey P; Pai P; Smith LM; Mo YY; Batra SK
Oncotarget; 2015 Nov; 6(37):40295-309. PubMed ID: 26516699
[TBL] [Abstract][Full Text] [Related]
14. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
15. Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1-Cre and LSL-Kras
Yu W; Ma Y; Roy SK; Srivastava R; Shankar S; Srivastava RK
J Cell Mol Med; 2022 Jan; 26(2):399-409. PubMed ID: 34859959
[TBL] [Abstract][Full Text] [Related]
16. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.
Barkeer S; Chugh S; Karmakar S; Kaushik G; Rauth S; Rachagani S; Batra SK; Ponnusamy MP
BMC Cancer; 2018 Nov; 18(1):1157. PubMed ID: 30466404
[TBL] [Abstract][Full Text] [Related]
17. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.
Kaur S; Smith LM; Patel A; Menning M; Watley DC; Malik SS; Krishn SR; Mallya K; Aithal A; Sasson AR; Johansson SL; Jain M; Singh S; Guha S; Are C; Raimondo M; Hollingsworth MA; Brand RE; Batra SK
Am J Gastroenterol; 2017 Jan; 112(1):172-183. PubMed ID: 27845339
[TBL] [Abstract][Full Text] [Related]
18. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.
Dong Y; Zhou L; Zhao D; Li K; Liu Z; Che N; Liu H
Jpn J Clin Oncol; 2020 Jun; 50(6):701-711. PubMed ID: 32083303
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer.
Hoshi H; Sawada T; Uchida M; Saito H; Iijima H; Toda-Agetsuma M; Wada T; Yamazoe S; Tanaka H; Kimura K; Kakehashi A; Wei M; Hirakawa K; Wanibuchi H
Int J Oncol; 2011 Mar; 38(3):619-27. PubMed ID: 21249315
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer.
Zhang J; Wang Y; Zhao T; Li Y; Tian L; Zhao J; Zhang J
World J Surg Oncol; 2020 Feb; 18(1):31. PubMed ID: 32028958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
